Characterizing the Interplay of Lymphocytes in Graves’ Disease
Graves’ disease (GD) is a thyroid-specific autoimmune disease with a high prevalence worldwide. The disease is primarily mediated by B cells, which produce autoantibodies against the thyroid-stimulating hormone receptor (TSHR), chronically stimulating it and leading to high levels of thyroid hormone...
Main Authors: | Mackenzie Hansen, Abigail Cheever, K. Scott Weber, Kim L. O’Neill |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/7/6835 |
Similar Items
-
TSHR169 Antigen Specifically Binds to the Thyroid-stimulating Autoantibody, Representing an Effective Biomarker for Graves’ Disease
by: Zulkarnain Zulkarnain, et al.
Published: (2019-03-01) -
Is There Evidence for IGF1R-Stimulating Abs in Graves’ Orbitopathy Pathogenesis?
by: Christine C. Krieger, et al.
Published: (2020-09-01) -
Bioassays for TSH receptor autoantibodies, from FRTL-5 cells to TSH receptor–LH/CG receptor chimeras: the contribution of Leonard D. Kohn
by: Cesidio Giuliani, et al.
Published: (2016-07-01) -
ELF3-induced miR-182 inhibits adipogenic differentiation in Graves’ orbitopathy by targeting thyrotropin receptor
by: Sha Wang, et al.
Published: (2023-01-01) -
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
by: Jing Ding, et al.
Published: (2022-09-01)